PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS

Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Autoimmune Indications

INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS

TREATMENT OF VIRAL INFECTION

METHODS OF ADMINISTERING IMMUNOSUPPRESSANTS HAVING A SPECIFIED PHARMACODYNAMIC EFFECTIVE LIFE AND THERAPEUTIC MACROMOLECULES FOR THE INDUCTION OF IMMUNE TOLERANCE

Combination therapies for the treatment of cancer

Expression of novel cell tags

Binding molecules for BCMA and CD3

Humanised Anti Kallikrein-2 Antibody

ANTIBODIES AND METHODS OF USE

Bispecific antibodies

NOVEL POLYPEPTIDES

Cross species single domain antibodies targeting mesothelin for treating solid tumors

Therapeutic anti-CD9 antibody

BINDING MOLECULE SPECIFIC FOR CD73 AND USE OF BINDING MOLECULE

Anti-CD20 antibody

Human monoclonal antibody human CD134 (OX40) and methods of making and using same

Multivalent and multispecific DR5-binding fusion proteins and methods of modulating immune cells

MULTIVALENT AND MULTIEPITOPIC ANTIBODIES HAVING AGONISTIC ACTIVITY AND METHODS OF USE

The use of anti-CCR7 mabs for the prevention or treatment of graft-versus-host disease (GvHD)

Treatment of Non-Small Cell Lung Cancer with EGFR Mutations

Methods of treating cancer pain by administering a PD-1 inhibitor

Anti-CTLA-4 Binding Proteins and Methods of Use Thereof

Anti-PD-1 Binding Proteins and Methods of Use Thereof

ANTI-CTLA4 ANTIBODIES AND METHODS OF USE THEREOF

ICOS BINDING PROTEINS

ANTI-TCR ANTIBODY MOLECULES AND USES THEREOF

BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES

MULTISPECIFIC ANTIGEN BINDING PROTEINS CAPABLE OF BINDING CD19 AND CD3, AND USE THEREOF

Antibodies to TIGIT

Drug regulated transgene expression

Anti-Human Transferrin Receptor Antibody Permeating Blood-Brain Barrier

ANTI-CD98hc ANTIBODY

Antibody binding to human IL-1β, preparation method therefor and use thereof

Polypeptides comprising immunoglobulin single variable domains targeting TNFA and IL-23

Use of anti-FAM19A5 antibodies for treating atherosclerosis

LTBP complex-specific inhibitors of TGFβ and uses thereof

Isoform-selective TGFB1 inhibitors and use thereof

SINGLE CHAIN INTRABODIES THAT ALTER HUNTINGTIN MUTANT DEGRADATION

T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF

PREPARATION COMPRISING ANTI-PCSK9 ANTIBODY AND USE THEREOF

Methods of Treating Multiple Myeloma

Stable Anti-OSMR Antibody Formulation

TREATMENT OF PSYCHIATRIC CONDITIONS

Human application of engineered chimeric antigen receptor (CAR) T-cells

Method of administration and treatment

Dynamic I/O virtualization system having guest memory management for mapping virtual addresses using virtualization application programming interface (API) in guest kernal

Anti-human nicotinamide phosphoribosyltransferase (NAMPT) antibodies

NOVEL POLYPEPTIDES

Anti-mesothelin antibody and antibody drug conjugate thereof

FGFR3 antibodies and methods of use

Anti-FLTantigen binding proteins

Lym-1 and Lym-2 antibody compositions and improved car constructs

BIFUNCTIONAL ANTI-PD-1/SIRPA MOLECULE

Monoclonal antibodies that bind specifically to human TRBV9

Security of dynamic I/O virtualization system having a bidirectional extended hybrid address space (EHAS) for allowing host kernel to access guest memory

Checkpoint blockade and microsatellite instability

Anti-LILRB2 antibodies and methods of use thereof

Treatment of eosinophil or mast cell related disorders

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

USE OF IL-1BETA BINDING ANTIBODIES

Human IL-23 antigen binding proteins

METHODS OF TREATING OCULAR PATHOLOGIES USING BIFUNCTIONAL MOLECULES THAT TARGET GROWTH FACTORS

Methods for Preventing and Treating Cardiac Dysfunction and COVID-19 with Activin A Antagonists

ADMINISTRATION OF AN ANTI-C5 AGENT FOR TREATMENT OF HEPATIC INJURY OR FAILURE

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

Anti-O1 antibodies and uses thereof

COMBINATION HBV THERAPY

D-domain containing polypeptides and uses thereof

Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

Anti-IL-23 antibodies, compositions, methods and uses

Humanized influenza monoclonal antibodies and methods of use thereof

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Dendritic cell ASGPR targeting immunotherapeutics for multiple sclerosis

GLIAL FIBRILLARY ACIDIC PROTEIN TARGETING IMMUNO- AND APTAMER-BASED-THERAPY FOR NEUROINJURY, NEURODEGENERATION, NEURO-DISEASE, AND NEURO-REPAIR

PKS-ISLAND POSITIVE E. COLI AS MARKER OF NEGATIVE RESPONSE TO ANTI-PD1 THERAPY IN COLORECTAL CANCER

Vaccine for immunocompromised hosts

ANTAGONISTS

Antibody for Specifically Binding to Lysyl-tRNA Synthetase N-Terminal Domain Exposed to Extracellular Membrane

Antibodies

Anti-Abeta Antibodies

ANTI-CD40 ANTIBODIES AND METHODS OF USE

ANTI-CD40 ANTIBODIES AND METHODS OF USE

Engineered immune cells targeting BCMA and their uses thereof

METHODS OF TREATING INFLAMMATION

TREATMENT OF ACUTE GVHD USING DONOR- SPECIFIC ANTI-HLA ANTIBODIES

Antibodies

VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER

Antibody molecules that bind CD137 and OX40

USE OF AN INHIBITOR OF NTSR1 ACTIVATION OR EXPRESSION FOR PREVENTING WEIGHT LOSS, MUSCLE LOSS, AND PROTEIN BLOOD LEVEL DECREASE IN SUBJECTS IN NEED THEREOF

Humanized and affinity matured antibodies to FcRH5 and methods of use

Antibodies against ILT2 and use thereof

Methods for Promoting Reinnervation of Auditory Hair Cells

METHOD OF TREATMENT TO PREVENT OR REVERSE AGE-ASSOCIATED INFLAMMATION, COGNITIVE DECLINE, AND NEURODEGENERATION

PREVENTING, TREATING, AND REDUCING (PERSISTENT) POST-TRAUMATIC HEADACHE

Anti-IL-6 antibody

Anti-Alpha-Synuclein Antibodies and Uses Thereof

csPCNA Isoform Antibodies And Uses Thereof

Treatment of staphylococcal disorders

Relaxin immunoglobulin fusion proteins and methods of use

COMBINATION THERAPIES WITH ANTI-FOLATE RECEPTOR ANTIBODY CONJUGATES

LYMPHANGIOGENESIS FOR THERAPEUTIC IMMUNOMODULATION

METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY

Method of administration and treatment

BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICROENVIRONMENT

METHODS TO PRESERVE TUMOR-STROMAL INTERACTIONS IN CULTURE AND THERAPEUTIC PREDICTIVE APPLICATIONS THEREOF

Heterodimeric antibodies that bind CD3 and tumor antigens

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

Anti-HER2/anti-4-1BB bispecific antibodies and uses thereof

ANTIBODIES SPECIFIC TO MUC18

Anti-CD38 antibodies and methods of use

BAFF-R antibodies and uses thereof

Methods for treating multiple myeloma

ANTIBODY MOLECULES

Bispecific antibody targeting IL-1R1 and NLPR3

Anti-ALK2 antibody

Anti-FGFR2 antibodies in combination with chemotherapy agents in gastric cancer

METHODS OF TREATING CANCER WITH AN ANTI-PD-L1 ANTIBODY

METHODS OF TREATING TUMOR

METHODS OF REDUCING LIVER PD-1-EXPRESSING CD8+ T CELLS USING PD-1 FC FUSION PROTEINS THAT BIND FC RECEPTORS

Combination Therapy for the Treatment of Cancer

Antibodies and nucleotide sequences, and uses thereof

Methods and compositions for preventing type 1 diabetes

FUSION PROTEIN OF SINGLE DOMAIN ANTIBODY AND PROCOAGULANT

Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof

TARGETED IMMUNOTOLERANCE

Treatment of brain ischemia-reperfusion injury

ANTI-FGF19 ANTIBODIES

Anti-Abeta antibodies

Anti-Abeta antibodies

Anti-abeta antibodies

METHOD FOR PREVENTING OR TREATING NOSOCOMIAL PNEUMONIA

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS)

REGULATABLE CELL SURFACE RECEPTORS AND RELATED COMPOSITIONS AND METHODS

Method of promoting wound healing by inhibiting CCR3

METHODS OF TREATING OCULAR CANCER USING ANTI-MET ANTIBODIES AND BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND MET

Anti-IL-6 Antibody Formulation

METHODS OF TREATING CROHN'S DISEASE

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Growth hormone antagonist and anti-cancer composition combination therapy

Method of administration and treatment

Combination therapies using immuno-dash inhibitors and PGE2 antagonists

AURIS FORMULATIONS FOR TREATING OTIC DISEASES AND CONDITIONS

Auris formulations for treating otic diseases and conditions

Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy

Materials and methods for multidirectional biotransportation in virotherapeutics

Compositions and methods for treatment of diabetic macular edema

MODIFIED ANTIBODY FCS AND METHODS OF USE

ErbB2 SIGNALING AND NERVE REGENERATION

Antibody specific for Mucin-1 and methods of use thereof

Bispecific antibody targeting IL-1R1 and NLPR3

Proteins comprising HLA-G antigen binding domains and their uses

Anti PD-L1 Conjugates for Treating Tumors

Methods for upregulating immune responses using combinations of anti-RGMb and anti-PD-1 agents

ANTI-HUMAN TIM-3 MONOCLONAL ANTIBODY AND APPLICATION THEREOF

Anti-human CD45RC antibodies and uses thereof

Antibody to fibrosis-related molecule and medical application thereof

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

Anti-ILT4 antibodies and antigen-binding fragments

Neutralizing anti-influenza A antibodies and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

T-cell modulatory multimeric polypeptides and methods of use thereof

In vivo methods for selecting peptides that cross the blood brain barrier, related compositions and methods of use

Conjugates of tumor necrosis factor inhibitors to functionalized polymers

LAG-3 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF

Inhibition of cytokine-induced SH2 protein in NK cells

Bispecific antibodies and uses thereof

TETRAHEDRAL ANTIBODIES

Muscle targeting complexes and uses thereof for treating dystrophinopathies

LYSOSOMAL STORAGE DISORDER BIOMARKERS AND METHODS OF USE THEREOF

Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs

BCMA antibodies and use of same to treat cancer and immunological disorders

COMBINATION THERAPIES FOR TREATING DISEASE USING AN INNATE IMMUNITY MODIFIER AND AN OX40 AGONIST

ANTI-CD40 ANTIBODY, ANTIGEN BINDING FRAGMENTAND PHARMACEUTICAL USE THEREOF

Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)

LEUCOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR NEUTRALIZING ANTIBODIES

Fully human antibodies that bind to vascular endothelial growth factor receptor 2 (VEGFR2) and methods of use thereof for treatment

Methods of Inhibiting Metastasis in Cancer

Immunosuppresive agent

TREATMENT OF HODGKIN LYMPHOMA USING AN ANTI-PD-1 ANTIBODY

Inhibition of cytokine-induced SH2 protein in NK cells

Bispecific antigen binding molecules targeting OX40 and FAP

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

Markers of acute myeloid leukemia stem cells

Humanized and affinity-matured anti-CEACAM1 antibodies

METHODS FOR TREATING DYSREGULATED LIPID METABOLISM

USE OF A CD6 BINDING PARTNER AND METHOD BASED THEREON

METHODS OF TREATING IMMUNOTHERAPY-RELATED TOXICITY USING A GM-CSF ANTAGONIST

METHODS FOR TREATING SPINAL CORD INJURY AND PAIN

Human antibodies to human delta like ligand 4

Human antibodies to Fel d1 and methods of use thereof

ANTI-APOC3 ANTIBODIES AND METHODS OF USE THEREOF

Anti-ETEC adhesin protein antibodies and methods of use

Neutralizing anti-influenza b antibodies and uses thereof

HETERODIMERIC PROTEINS FOR MODULATING GAMMA DELTA T CELLS

Readily isolated bispecific antibodies with native immunoglobulin format

Humanized anti-CD79B antibodies and immunoconjugates and methods of use

Method of administration and treatment

Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer

Bispecific antibodies and uses thereof

METHOD OF TREATING ATHEROSCLEROSIS

MAGEB2 binding constructs

Humanized BCMA antibody and BCMA-CAR-T cells

Anti-OX40 monoclonal antibody and application thereof

BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

Anti-TNFR2 antibody and use thereof

OX40 ANTIBODY, PREPARATION METHOD THEREOF AND USE THEREOF

Bispecific polypeptides for engagement of CAR expressing immune cells with antigen presenting cells and uses thereof

Antibodies against IL-7R alpha subunit and uses thereof

EGFR binding proteins and methods of use

Anti-alpha-4-beta-7 antibodies

Therapeutic antibodies and their uses

Combination Therapy for Cancer

USE OF TIM-3 ANTIBODY IN PREPARATION OF MEDICINES FOR TREATING TUMORS

STEM CELL FACTOR INHIBITOR

CELL-PENETRATING ANTI-DNA ANTIBODIES AND USES THEREOF INHIBIT DNA REPAIR

Methods of Treating Inflammatory Pain

MONOCLONAL ANTIBODIES AGAINST AMYLOID BETA PROTEIN AND USES THEREOF

HUMAN ANTIBODIES TARGETING ZIKA VIRUS NS1, NS1 POLYPEPTIDES AND USES THEREOF

ANTI-SARS-CoV-2 MONOCLONAL ANTIBODIES

TGF-beta RECEPTOR FUSION PROTEIN PHARMACEUTICAL COMPOSITION AND USE THEREOF

Dual cytokine fusion proteins comprising IL-10

Antibody drug conjugates (ADCS) having enzymatically cleavable groups

ANTI-CDH6 ANTIBODY-PYRROLOBENZODIAZEPINE DERIVATIVE CONJUGATE

IMMUNO ONCOLOGY COMBINATION THERAPY WITH IL-2 CONJUGATES AND ANTI-EGFR ANTIBODIES

PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION

METHODS AND COMPOSITIONS FOR TREATING CANCER

METHOD OF ADMINISTRATION AND TREATMENT

METHOD OF ADMINISTRATION AND TREATMENT

COMBINATION THERAPY FOR TREATMENT OF CANCER

COMBINATION TREATMENT OF HIV INFECTIONS

Anti-kit antibodies and uses thereof

Anti-GARP antibody

Anti-human CD52 immunoglobulins

BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS

Targeting intraepithelial lymphocytes for treatment of metabolic syndrome

Treatment of metastatic pancreatic adenocarcinoma

ANTIBODIES BINDING TO CD3

Antibodies binding to CD3 and CD19

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

ANTIBODIES SPECIFIC FOR IMMUNOGLOBULIN-LIKE TRANSCRIPT 3 (ILT3) AND USES THEREOF

Inhibitors of neuroligin 4-neurexin 1-beta protein-protein interaction for treatment of liver disorders

ANTI-TNFALPHA/ANTI IL - 17A NATURAL ANTIBODY STRUCTURE-LIKE HETERODIMER FORM OF BISPECIFIC ANTIBODY AND PREPARATION METHOD THEREFOR

HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS

PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY IN ALZHEIMER'S DISEASE

COMBINATION OF RADIOIMMUNOTHERAPY AND IMMUNE CHECKPOINT THERAPY IN THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS FOR THE TREATMENT AND/OR PREVENTION OF TYPE 1 DIABETES

Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer

Combined treatment of primary central nervous system lymphoma

Genetically engineered hematopoietic stem cells and uses thereof

Combination therapy with notch and PD-1 or PD-L1 inhibitors

Pharmaceutical Composition for Treating B-Cell Lymphoma

COMBINATION ANTI-CANCER PRODUCTS AND METHODS

Compounds and methods for use in detecting gabapentin

CD146 AND USES THEREOF AS A BIOMARKER AND AS A THERAPEUTIC TARGET IN THE DIAGNOSIS AND TREATMENT OF FIBROSIS

ANTI-CEA ANTIBODIES

Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation

METHODS OF TREATING CANCERS USING PD-1 AXIS BINDING ANTAGONISTS AND TAXANES

ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE

BRAIN TARGETED DRUG DELIVERY METHOD VIA SYNDECAN-3

BISPECIFIC ANTIBODY BINDING TO CD20 AND CD3 AND USES THEREOF

IMMUNOGLOBULIN VARIANTS AND USES THEREOF

BINDING MOLECULES TO THE HUMAN OX40 RECEPTOR

BISPECIFIC ANTIBODY AGAINST BCMA AND CD3 AND AN IMMUNOLOGICAL DRUG FOR COMBINED USE IN TREATING MULTIPLE MYELOMA

Agonistic anti TNFR2 antibody molecules

Antigen Binding Proteins that Bind c-Met

Anti-PD-L1/VEGF bifunctional antibody and use thereof

Antibodies binding CTLA-4 and uses thereof

Treatment of renal cell carcinoma

Humanized anti-PD-1 antibody and the use thereof

Targeted Immunotolerance

HOMODIMER-TYPE BISPECIFIC ANTIBODY TARGETING CD19 AND CD3, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Anti-ILT4 antibodies and antigen-binding fragments

METHODS OF TREATING GRAVES' OPHTHALMOPATHY USING ANTI-FCRN ANTIBODIES

CHIMERIC ANTIGEN RECEPTOR AND ITS USE

Methods of treating allergy using anti-Bet v 1 antibodies

Broadly-neutralizing anti-HIV antibodies

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

Modified monocytes/macrophage expressing chimeric antigen receptors and uses thereof

HPK1 INHIBITORS AND METHODS OF USING SAME

Compositions including a therapeutic antibodies and/or a checkpoint inhibitor and an integrin activating compound

Modified Cell Expressing Therapeutic Agent and Uses thereof

Methods for inducing an immune response

Pertuzumab plus trastuzumab fixed dose combination

Bispecific antigen-binding constructs targeting HER2

Antibodies to mucin-16 (MUC16), encoding polynucleotides and methods of treating MUC16-positive cancer

Chimeric antigen receptor

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bind PSMA and CD3, and Uses Thereof

EPCAM ANTIBODIES, ACTIVATABLE ANTIBODIES, AND IMMUNOCONJUGATES, AND USES THEREOF

Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38

COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES

Anti-CD40 antibodies and uses thereof

MUTANT OF RANKL AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING OR TREATING OSTEOPOROSIS

METHODS AND COMPOSITIONS FOR INCREASING GALACTOSIDASE BETA-1 ACTIVITY IN THE CNS